Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is associated with gastrointestinal motility abnormalities that could favor the occurrence of small intestinal bacterial overgrowth (SIBO). The aim of the study was to assess the prevalence of SIBO in Chinese patients with PD and the potential impact of SIBO on gastrointestinal symptoms and motor function. 182 consecutive Chinese patients with PD patients and 200 sex, age, and BMI-matched subjects without PD were included. All participants underwent the glucose breath test to assess SIBO. We examined the associations between factors and SIBO with logistic regression using SPSS. Fifty-five of the 182 PD patients were SIBO positive (30.2 %; 95 % CI 23.5-36.9 %) compared with 19 of 200 in the control group (9.5 %; 95 % CI 5.4-13.6 %); the difference was statistically significant (P < 0.0001; OR 4.13; 95 % CI 2.34-7.29). Motor fluctuations present was higher in the PD patients with SIBO than in the patients without SIBO (70.9 vs. 45.7 %; P = 0.002). Multivariate analysis showed that disease duration, Hoehn and Yahr stage, Unified PD Rating-III score, Unified PD Rating-IV score, and Non-Motor Symptoms Scale score were the factors associated with the SIBO-positive status in PD patients. SIBO was highly prevalent in PD, and nearly one-third was detected. SIBO was associated with worse gastrointestinal symptoms and worse motor function. Further studies are needed to specify the reasons underlying SIBO and worse motor function in PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, the positive rate of small intestinal bacterial overgrowth in patients with Parkinson's disease was found to be significantly increased, and it was associated with the deterioration of gastrointestinal symptoms and motor function.61”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [61]
Citations
Cites
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822 · cited 1×
“The study enrolled 182 consecutive outpatients and inpatients that fulfilled the following inclusion criteria: the diagnosis of PD according to the criteria of the UK Brain Bank (Gelb et al. 1999) and the occurrence of motor fluctuations (assessed by Niu and Li).”
MethodGoetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,347 · cited 1×
“Y) stage (Goetz et al. 2004).”
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · cited 3×
“Gastrointestinal dysfunction, in particular constipation, affects up to 80 % of PD patients and may precede the onset of motor symptoms by years (Scheperjans et al. 2015).”
BackgroundInfluentialThe Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations
Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease (2003) · Movement Disorders · doi:10.1002/mds.10473 · Cited by 1,810
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445 · cited 1×
“…GI dysfunction in patients with more advanced PD. GI dysfunction seems to be the most plausible pathophysiological link underlying the association between SIBO and PD. GI motility dysfunction is manifesting mainly as dysphagia, disorders of gastric emptying, and constipation (Barone et al. 2009).”
BackgroundChaudhuri, K. R., Martinez‐Martin, P., Brown, R. G., Sethi, K., Stocchi, F., Odin, P., Ondo, W., Abe, K., MacPhee, G., MacMahon, D., et al. (2007) · Movement Disorders · doi:10.1002/mds.21596 · Cited by 1,087 · cited 4×
“Y Hoehn and Yahr, LEU levodopa equivalent units, UPDRS Unified PD Rating Scale, NMSS Non-Motor Symptoms Scale causal link between SIBO and motor function in PD.”
MethodInfluentialSmall intestinal bacterial overgrowth syndrome
Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620 · cited 1×
“Other potentially relevant, but hitherto unstudied, factors are geographic effects, dietary factors, including alcohol consumption, malnutrition, and possible alterations in gut and systemic immune function (Furnari et al. 2010; Bures et al. 2010).”
BackgroundROME III: The Functional Gastrointestinal Disorders
Sheth, A. A. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31804bbe26 · Cited by 489
Melancholic microbes: a link between gut microbiota and depression
Dinan, T. G., & Cryan, J. F. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12198 · Cited by 424 · cited 1×
“Furthermore, recent studies had demonstrated that there was a distinct perturbation of the composition of gut microbiota in animal models of depression and chronic stress (Dinan and Cryan 2013).”
BackgroundThe role of small intestinal bacterial overgrowth in Parkinson's disease
Fasano, A., Bove, F., Gabrielli, M., Petracca, M., Zocco, M. A., Ragazzoni, E., Barbaro, F., Piano, C., Fortuna, S., Tortora, A., et al. (2013) · Movement Disorders · doi:10.1002/mds.25522 · Cited by 344 · cited 8×
“Some studies suggested that SIBO could be associated with worse ‘‘on’’-medication motor scores and more severe motor fluctuations (Gabrielli et al. 2011; Fasano et al. 2013).”
BackgroundResultInfluentialSmall intestinal bacterial overgrowth in Parkinson's disease
Tan, A. H., Mahadeva, S., Thalha, A. M., Gibson, P. R., Kiew, C. K., Yeat, C. M., Ng, S. W., Ang, S. P., Chow, S. K., Tan, C. T., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.02.019 · Cited by 274 · cited 6×
“These agents cause hypochlorhydria, which in turn may cause bacterial overgrowth in the stomach and upper small intestine (Tan et al. 2014).”
BackgroundResultInfluentialRelationships between diet-related changes in the gut microbiome and cognitive flexibility
Magnusson, K. R., Hauck, L., Jeffrey, B. M., Elias, V., Humphrey, A., Nath, R., Perrone, A., & Bermudez, L. E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.016 · Cited by 225 · cited 1×
“One study suggested that changes in the microbiome may contribute to cognitive changes associated with eating a Western diet (Magnusson et al. 2015).”
BackgroundNucera, G., Gabrielli, M., Lupascu, A., Lauritano, E. C., Santoliquido, A., Cremonini, F., Cammarota, G., Tondi, P., Pola, P., Gasbarrini, G., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02493.x · Cited by 207
Parkinson's disease: Evidence for environmental risk factors
Kieburtz, K., & Wunderle, K. B. (2013) · Movement Disorders · doi:10.1002/mds.25150 · Cited by 199 · cited 1×
“The early involvement of the gastrointestinal tract in PD lends support to the hypothesis that the environmental factors exert its influences primarily via the gut flora (Kieburtz and Wunderle 2013).”
BackgroundHelicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations
Pierantozzi, M., Pietroiusti, A., Brusa, L., Galati, S., Stefani, A., Lunardi, G., Fedele, E., Sancesario, G., Bernardi, G., Bergamaschi, A., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000221672.01272.ba · Cited by 199
Prevalence of small intestinal bacterial overgrowth in Parkinson’s disease
Gabrielli, M., Bonazzi, P., Scarpellini, E., Bendia, E., Lauritano, E. C., Fasano, A., Ceravolo, M. G., Capecci, M., Rita Bentivoglio, A., Provinciali, L., et al. (2011) · Movement Disorders · doi:10.1002/mds.23566 · Cited by 175
Small Intestinal Bacterial Overgrowth: Diagnosis and Treatment
Gasbarrini, A., Lauritano, E. C., Gabrielli, M., Scarpellini, E., Lupascu, A., Ojetti, V., & Gasbarrini, G. (2007) · Digestive Diseases · doi:10.1159/000103892 · Cited by 159 · cited 4×
“Small intestinal bacterial overgrowth (SIBO) is a malabsorption syndrome associated with increased bacterial density above 105 colony-forming units/mL of small intestinal aspirate and/or the presence of colonic-type species (Gasbarrini et al. 2007).”
BackgroundInfluentialEffects of gastrointestinal inflammation on enteroendocrine cells and enteric neural reflex circuits
Lomax, A. E., Linden, D. R., Mawe, G. M., & Sharkey, K. A. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.02.015 · Cited by 143 · cited 2×
“tion effects on enterochromaffinlike cells (Lomax et al. 2006).”
BackgroundAssociation between hypothyroidism and small intestinal bacterial overgrowth
Lauritano, E. C., Bilotta, A. L., Gabrielli, M., Scarpellini, E., Lupascu, A., Laginestra, A., Novi, M., Sottili, S., Serricchio, M., Cammarota, G., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0606 · Cited by 140 · cited 1×
“Previous studies found that diseases associated with impaired gastrointestinal (GI) motility, such as diabetes mellitus and hypothyroidism, are predisposing factors for the development of SIBO (Zietz et al. 2000; Lauritano et al. 2007).”
BackgroundSmall intestinal bacterial overgrowth
Rana, S. V., & Bhardwaj, S. B. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520801947074 · Cited by 139
Parlesak, A., Klein, B., Schecher, K., Bode, J. C., & Bode, C. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1365-2389.2003.51259.x · Cited by 111 · cited 1×
“The prevalence of SIBO in PD reported in recent studies ranged from 54 to 67 % (Fasano et al. 2013; Dobbs et al. 2013; Parlesak et al. 2003).”
BackgroundFurnari, M., Parodi, A., Gemignani, L., Giannini, E. G., Marenco, S., Savarino, E., Assandri, L., Fazio, V., Bonfanti, D., Inferrera, S., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04436.x · Cited by 86 · cited 2×
“Importantly, breath tests for SIBO have not been standardized, and protocols differ with respect to the substrate used, sampling intervals, and test interpretation (Furnari et al. 2010).”
BackgroundDysautonomia and cognitive dysfunction in Parkinson's disease
Poewe, W. (2007) · Movement Disorders · doi:10.1002/mds.21681 · Cited by 63 · cited 2×
“In addition, autonomic and cognitive dysfunctions are among the most prevalent of these non-motor aspects of the disease (Poewe 2007).”
BackgroundParkinson's disease research in a prospective cohort in China
Chen, H., Ding, D., Wang, J., Zhao, Q., Meng, H., Li, H., Gao, Y.-T., Shu, X., Tanner, C. M., Hong, Z., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.08.020 · Cited by 44 · cited 1×
“Research efforts in China have been limited, despite the fact that China has the largest elderly population and is believed to have the largest PD population worldwide (Chen et al. 2015).”
BackgroundSelf-citationZietz, B., Lock, G., Straub, R. H., Braun, B., Schölmerich, J., & Palitzsch, K. D. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1200 · Cited by 38 · cited 2×
“Previous studies found that diseases associated with impaired gastrointestinal (GI) motility, such as diabetes mellitus and hypothyroidism, are predisposing factors for the development of SIBO (Zietz et al. 2000; Lauritano et al. 2007).”
BackgroundBacterial Overgrowth and Methane Production in Children with Encopresis
Leiby, A., Mehta, D. I., Gopalareddy, V. V., Jackson-Walker, S., & Horváth, K. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.10.043 · Cited by 37 · cited 1×
“Study participants were considered to exhibit SIBO when an increase in H2 C 20 ppm or CH4 C 10 ppm with respect to the fasting value was observed up to 60 min after the ingestion of glucose (Leiby et al. 2010).”
MethodDobbs, S. M., Charlett, A., John Dobbs, R., Weller, C., Iguodala, O., Smee, C., Lawson, A. J., Taylor, D., & Bjarnason, I. (2013) · Helicobacter · doi:10.1111/hel.12035 · Cited by 36 · cited 1×
“The prevalence of SIBO in PD reported in recent studies ranged from 54 to 67 % (Fasano et al. 2013; Dobbs et al. 2013; Parlesak et al. 2003).”
Background
Cited by
Chen, Z., Li, G., & Liu, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104700 · Cited by 363
The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases
Spielman, L. J., Gibson, D. L., & Klegeris, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.005 · Cited by 266
“Intestinal microbial overgrowth, which is defined as an excessive increase in coliform bacteria, has been found to be common in PD patients (Gabrielli et al., 2011; Niu et al., 2016; Sachdev and Pimentel, 2013).”
Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management
Rao, S. S. C., & Bhagatwala, J. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000078 · Cited by 198
Metadata
- Authors
- Niu, X.-L., Liu, L., Song, Z.-X., Li, Q., Wang, Z.-H., Zhang, J.-L., & Li, H.-H.
- Affiliations
- First Affiliated Hospital of Xinxiang Medical University (CN)
- Venue
- Journal of Neural Transmission
- Published
- 2016-09-02
- Volume
- 123
- Issue
- 12
- Pages
- 1381-1386
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2510141755
- Semantic Scholar
- 9f9ee3e308ae31d9ea9d8acebe6bc2734ceb8cd5
- Cited by
- 64
- References
- 27
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 8 · 2022: 11 · 2021: 14 · 2020: 10 · 2019: 8 · 2018: 4 · 2017: 1
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Parkinson's disease, small intestinal bacterial overgrowth, prevalence, gastrointestinal motility, motor fluctuations, motor function, non-motor symptoms, disease duration, Hoehn and Yahr stage, Chinese patients
- MeSH terms
- Gastrointestinal Microbiome, Aged, Blind Loop Syndrome, Breath Tests, Female, Humans, Intestine, Small, Male, Middle Aged, Parkinson Disease, Body Mass Index, Prevalence, Case-Control Studies, Statistics, Nonparametric, Asian People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.